MCID: CNG029
MIFTS: 44

Congenital Mesoblastic Nephroma

Categories: Cancer diseases, Nephrological diseases, Rare diseases

Aliases & Classifications for Congenital Mesoblastic Nephroma

MalaCards integrated aliases for Congenital Mesoblastic Nephroma:

Name: Congenital Mesoblastic Nephroma 12 74 52 58 15 71
Nephroma, Mesoblastic 43
Mesoblastic Nephroma 17

Classifications:

Orphanet: 58  
Rare renal diseases


External Ids:

Disease Ontology 12 DOID:4773
MeSH 43 D018201
NCIt 49 C6569
MESH via Orphanet 44 D018201
ICD10 via Orphanet 33 D41.0
UMLS via Orphanet 72 C1332965
Orphanet 58 ORPHA2665
UMLS 71 C1332965

Summaries for Congenital Mesoblastic Nephroma

Disease Ontology : 12 A kidney cancer that is characterized by the presence of fibroblastic cells.

MalaCards based summary : Congenital Mesoblastic Nephroma, also known as nephroma, mesoblastic, is related to cellular congenital mesoblastic nephroma and nephroma. An important gene associated with Congenital Mesoblastic Nephroma is ETV6 (ETS Variant Transcription Factor 6), and among its related pathways/superpathways are Akt Signaling and Nanog in Mammalian ESC Pluripotency. The drugs Fentanyl and Pancreatic Polypeptide have been mentioned in the context of this disorder. Affiliated tissues include kidney, liver and brain, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 74 Congenital mesoblastic nephroma, while rare, is the most common kidney neoplasm diagnosed in the first... more...

Related Diseases for Congenital Mesoblastic Nephroma

Diseases related to Congenital Mesoblastic Nephroma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 177)
# Related Disease Score Top Affiliating Genes
1 cellular congenital mesoblastic nephroma 32.6 YWHAE VGLL2 SSX2 NUTM2B NTRK3 ETV6
2 nephroma 32.3 WT1 NTRK3 KIT IGF2 ETV6
3 wilms tumor 1 31.2 WT1 KIT IGF2 CTCF
4 breast secretory carcinoma 31.1 NTRK3 ETV6
5 hemihyperplasia, isolated 31.1 WT1 IGF2
6 rhabdoid cancer 31.0 WT1 SSX2 BCOR
7 fibrosarcoma 31.0 SSX2 NTRK3 NTRK1 KIT ETV6
8 kidney rhabdoid cancer 30.6 YWHAE NUTM2B CCNB3 BCOR
9 spindle cell sarcoma 30.6 SSX2 NTRK3 CCNB3
10 leiomyoma 30.5 MKI67 KIT IGF2
11 clear cell sarcoma 30.2 YWHAE WT1 NUTM2B KIT IGF2 CCNB3
12 mesenchymal cell neoplasm 30.2 SSX2 NTRK3 KIT CCNB3 BCOR
13 neuroblastoma 30.0 NTRK3 NTRK2 NTRK1 NRAS KIT IGF2
14 rhabdomyosarcoma 29.9 WT1 VGLL2 SSX2 KIT IGF2
15 congenital fibrosarcoma 29.8 VGLL2 NTRK3 NTRK2 NTRK1 ETV6 CCNB3
16 kidney clear cell sarcoma 29.5 YWHAE VGLL2 NUTM2B NTRK3 CCNB3 BCOR
17 kidney sarcoma 29.0 YWHAE WT1 VGLL2 SSX2 NUTM2B CCNB3
18 classic congenital mesoblastic nephroma 12.6
19 infantile myofibromatosis 11.8
20 myofibromatosis, infantile, 1 11.5
21 graham boyle troxell syndrome 11.5
22 wilms tumor 5 10.9
23 polyhydramnios 10.8
24 chromosomal triplication 10.7
25 rare tumor 10.6
26 rare renal tumor 10.6
27 congenital heart defects, hamartomas of tongue, and polysyndactyly 10.6
28 hydrops fetalis, nonimmune 10.6
29 rhabdoid tumor predisposition syndrome 1 10.5
30 pregnancy adenoma 10.5 NTRK3 ETV6
31 pax6-related aniridia 10.5 WT1 IGF2
32 adult fibrosarcoma 10.5 NTRK3 ETV6
33 testicular gonadoblastoma 10.5 WT1 KIT
34 small intestine leiomyosarcoma 10.5 KIT IGF2
35 uterine sarcoma 10.5 WT1 KIT
36 lipid-rich carcinoma 10.5 NTRK3 ETV6
37 breast adenoid cystic carcinoma 10.5 NTRK3 ETV6
38 colon leiomyosarcoma 10.5 WT1 KIT
39 adenofibroma 10.5
40 nephrogenic adenofibroma 10.5
41 pulmonary vein stenosis 10.5 MKI67 KIT
42 ovarian mixed germ cell neoplasm 10.5 WT1 KIT
43 benign fibrous mesothelioma 10.5 KIT IGF2
44 malignant anus melanoma 10.5 NRAS KIT
45 malignant dermis tumor 10.5 NRAS KIT
46 acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) 10.5 KIT ETV6
47 hypereosinophilic syndrome, idiopathic 10.5 WT1 KIT
48 uterine corpus sarcoma 10.4 NTRK1 KIT
49 malignant skin fibrous histiocytoma 10.4 NRAS KIT
50 small intestinal sarcoma 10.4 NTRK1 KIT

Graphical network of the top 20 diseases related to Congenital Mesoblastic Nephroma:



Diseases related to Congenital Mesoblastic Nephroma

Symptoms & Phenotypes for Congenital Mesoblastic Nephroma

GenomeRNAi Phenotypes related to Congenital Mesoblastic Nephroma according to GeneCards Suite gene sharing:

26 (show all 24)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-1 9.81 SSX2
2 Increased shRNA abundance (Z-score > 2) GR00366-A-100 9.81 SSX2 WT1
3 Increased shRNA abundance (Z-score > 2) GR00366-A-122 9.81 WT1
4 Increased shRNA abundance (Z-score > 2) GR00366-A-137 9.81 NTRK3
5 Increased shRNA abundance (Z-score > 2) GR00366-A-145 9.81 WT1
6 Increased shRNA abundance (Z-score > 2) GR00366-A-148 9.81 NTRK3
7 Increased shRNA abundance (Z-score > 2) GR00366-A-149 9.81 SSX2
8 Increased shRNA abundance (Z-score > 2) GR00366-A-152 9.81 KIT NTRK3 WT1
9 Increased shRNA abundance (Z-score > 2) GR00366-A-157 9.81 KIT
10 Increased shRNA abundance (Z-score > 2) GR00366-A-170 9.81 KIT
11 Increased shRNA abundance (Z-score > 2) GR00366-A-191 9.81 SSX2
12 Increased shRNA abundance (Z-score > 2) GR00366-A-214 9.81 WT1
13 Increased shRNA abundance (Z-score > 2) GR00366-A-30 9.81 KIT NTRK3 SSX2 WT1
14 Increased shRNA abundance (Z-score > 2) GR00366-A-41 9.81 NTRK3
15 Increased shRNA abundance (Z-score > 2) GR00366-A-42 9.81 NTRK3
16 Increased shRNA abundance (Z-score > 2) GR00366-A-43 9.81 WT1
17 Increased shRNA abundance (Z-score > 2) GR00366-A-47 9.81 WT1
18 Increased shRNA abundance (Z-score > 2) GR00366-A-60 9.81 NTRK3
19 Increased shRNA abundance (Z-score > 2) GR00366-A-61 9.81 KIT
20 Increased shRNA abundance (Z-score > 2) GR00366-A-77 9.81 SSX2
21 Increased shRNA abundance (Z-score > 2) GR00366-A-85 9.81 KIT NTRK3 WT1
22 Increased shRNA abundance (Z-score > 2) GR00366-A-9 9.81 KIT
23 Increased shRNA abundance (Z-score > 2) GR00366-A-99 9.81 KIT
24 Increased senescence-associated beta-galactosidase protein expression after pRB stimulation GR00230-A-2 8.65 NTRK2

MGI Mouse Phenotypes related to Congenital Mesoblastic Nephroma:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10 AGBL4 BCOR CCNB3 CTCF ETV6 IGF2
2 mortality/aging MP:0010768 9.97 AGBL4 BCOR CTCF ETV6 IGF2 KIT
3 no phenotypic analysis MP:0003012 9.56 ETV6 IGF2 KIT MKI67 NRAS NTRK1
4 normal MP:0002873 9.23 ETV6 KIT MKI67 NRAS NTRK1 NTRK2

Drugs & Therapeutics for Congenital Mesoblastic Nephroma

Drugs for Congenital Mesoblastic Nephroma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 20)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
2 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
3 Liver Extracts Phase 3
4 Anesthetics Phase 3
5 Narcotics Phase 3
6 Cola Phase 3
7 Analgesics Phase 3
8 Analgesics, Opioid Phase 3
9 Anesthetics, General Phase 3
10 Anesthetics, Intravenous Phase 3
11
Entrectinib Approved, Investigational Phase 1, Phase 2 1108743-60-7 25141092
12
Ifosfamide Approved Phase 1, Phase 2 3778-73-2 3690
13
Dasatinib Approved, Investigational Phase 1, Phase 2 302962-49-8 3062316
14
Etoposide Approved Phase 1, Phase 2 33419-42-0 36462
15
Carboplatin Approved Phase 1, Phase 2 41575-94-4 10339178 38904 498142
16
Tyrosine Approved, Investigational, Nutraceutical Phase 1, Phase 2 60-18-4 6057
17 Protein Kinase Inhibitors Phase 1, Phase 2
18 Etoposide phosphate Phase 1, Phase 2
19 Alkylating Agents Phase 1, Phase 2
20
Isophosphamide mustard Phase 1, Phase 2 0

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
2 A Phase 1/2, Open-Label, Dose-Escalation And Expansion Study Of Entrectinib (Rxdx-101) In Pediatrics With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options Recruiting NCT02650401 Phase 1, Phase 2 Entrectinib
3 Dasatinib With Ifosfamide, Carboplatin, Etoposide: A Pediatric Phase I/II Trial Active, not recruiting NCT00788125 Phase 1, Phase 2 carboplatin;dasatinib;etoposide phosphate;ifosfamide
4 A Population Based Study of Genetic Predisposition and Gene-Environment Interactions in Cancer in East Anglia, Trent and West Midlands Unknown status NCT00757614
5 The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study Recruiting NCT02402244
6 Renal Tumors Classification, Biology, and Banking Study Suspended NCT00898365
7 Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN) Children s Oncology Group Terminated NCT01117168
8 Focal Adhesion Kinase Expression in Pediatric Renal Tumors Withdrawn NCT01642095

Search NIH Clinical Center for Congenital Mesoblastic Nephroma

Cochrane evidence based reviews: nephroma, mesoblastic

Genetic Tests for Congenital Mesoblastic Nephroma

Anatomical Context for Congenital Mesoblastic Nephroma

MalaCards organs/tissues related to Congenital Mesoblastic Nephroma:

40
Kidney, Liver, Brain, Bone, Testes, Lung, Breast

Publications for Congenital Mesoblastic Nephroma

Articles related to Congenital Mesoblastic Nephroma:

(show top 50) (show all 325)
# Title Authors PMID Year
1
WT1 expression and hemihypertrophy in congenital mesoblastic nephroma. 54 61
19011477 2008
2
Duplication of the paternal IGF2 allele in trisomy 11 and elevated expression levels of IGF2 mRNA in congenital mesoblastic nephroma of the cellular or mixed type. 54 61
17639583 2007
3
KIT expression in normal and neoplastic renal tissues: immunohistochemical and molecular genetic analysis. 54 61
15998375 2005
4
Cryptic t(12;15)(p13;q26) producing the ETV6-NTRK3 fusion gene and no loss of IGF2 imprinting in congenital mesoblastic nephroma with trisomy 11: fluorescence in situ hybridization and IGF2 allelic expression analysis. 61 54
12165445 2002
5
ETV6 rearrangements in patients with infantile fibrosarcomas and congenital mesoblastic nephromas by fluorescence in situ hybridization. 61 54
11743047 2001
6
Insulin-like growth factor II gene expression by congenital mesoblastic nephroma. 61 54
8634785 1995
7
Good prognosis of cellular mesoblastic nephroma with hyperdiploidy and relaxation of imprinting of the maternal IGF2 gene. 61 54
8597855 1995
8
Recurrent EGFR alterations in NTRK3 fusion negative congenital mesoblastic nephroma. 61
32490123 2020
9
NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm. 61
32278476 2020
10
Congenital mesoblastic nephroma: a single-centre series. 61
31508997 2020
11
Diagnostic Utility of BCOR Antibody in Clear Cell Sarcomas of Kidney. 61
31875746 2019
12
Lessons learned from the developmental origins of childhood renal cancer. 61
31738020 2019
13
Re: Recurrent and Metastatic Congenital Mesoblastic Nephroma: Where Does the Evidence Stand? 61
31343939 2019
14
Laparoscopic management of congenital mesoblastic nephroma- case report. 61
31388496 2019
15
Prenatal diagnosis of congenital mesoblastic nephroma: a case with poor prognosis. 61
31466985 2019
16
Unusual Case of Concurrent Retroperitoneal Congenital Infantile Fibrosarcoma and Cellular Type Congenital Mesoblastic Nephroma. 61
31343481 2019
17
Paraneoplastic disorders associated with miscellaneous neoplasms with focus on selected soft tissue and Undifferentiated/ rhabdoid malignancies. 61
30819530 2019
18
The clinical presentation, imaging features and differential diagnoses of congenital Wilms tumour. 61
31151974 2019
19
Anaplastic sarcoma of the kidney: Case report and literature review. 61
31007495 2019
20
Neurotrophic tropomyosin or tyrosine receptor kinase (NTRK) genes. 61
30636697 2019
21
TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening. 61
30592640 2019
22
Specific computed tomography imaging characteristics of congenital mesoblastic nephroma and correlation with ultrasound and pathology. 61
30145031 2018
23
Estimated glomerular filtration rate after nephrectomy for Wilms tumor. 61
30003640 2018
24
Dramatic bone remodeling following larotrectinib administration for bone metastasis in a patient with TRK fusion congenital mesoblastic nephroma. 61
29893456 2018
25
Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. 61
29915264 2018
26
Evaluation of renal tumors in children. 61
29733801 2018
27
Fetal biparametric MR imaging in the diagnosis of congenital mesoblastic nephroma. 61
29733803 2018
28
ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study. 61
29286563 2018
29
Use of Pretherapy Core Biopsy in the Diagnosis of Pediatric Renal Tumors. 61
29681695 2018
30
Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy. 61
29099503 2018
31
Neonatal solid tumors. 61
28736178 2018
32
A rare cause of neonatal hypertension: Congenital mesoblastic nephroma. 61
30325129 2018
33
Congenital Mesoblastic Nephroma Presenting with Hematuria in a Neonate. 61
30464149 2018
34
Targeting NTRK fusions for the treatment of congenital mesoblastic nephroma. 61
28440051 2018
35
Recurrent and metastatic congenital mesoblastic nephroma: where does the evidence stand? 61
28856451 2017
36
Congenital mesoblastic nephroma 50 years after its recognition: A narrative review. 61
28124468 2017
37
Unusual Presentation of Metanephric Stromal Tumor in a Neonate. 61
29200690 2017
38
Cellular Congenital Mesoblastic Nephroma in a Newborn. 61
28770142 2017
39
Renal Tumors in Children Younger Than 12 Months of Age: A 65-Year Single Institution Review. 61
27820132 2017
40
Management of mixed type congenital mesoblastic nephroma: Case series and review of the literature. 61
28282819 2017
41
Congenital Mesoblastic Nephroma Presenting With Refractory Hypertension in a Premature Neonate: A Case Study. 61
28137351 2017
42
Cytological diagnosis of mesoblastic nephroma: A report of three cases with summary of prior published cases. 61
27324404 2016
43
[Congenital mesoblastic nephroma: a clinicopathologic analysis of 17 cases]. 61
27646897 2016
44
Uncommon renal tumors in children: A single center experience. 61
27046976 2016
45
Congenital Mesoblastic Nephroma Presenting With Hematuria in a Neonate: A Case Report. 61
26616096 2016
46
Congenital mesoblastic nephroma: Its diverse clinical features - A literature review with a case report. 61
26467634 2016
47
The Value of Mitotic Count and Ki67 Proliferation Index in Congenital Mesoblastic Nephroma. 61
27484189 2016
48
Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement. 61
27020209 2016
49
Mixed subtype of congenital mesoblastic nephroma with poor evolution: a case report and literature review. 61
26811558 2015
50
Congenital mesoblastic nephroma with focal anaplastic lesion. 61
25818639 2015

Variations for Congenital Mesoblastic Nephroma

Expression for Congenital Mesoblastic Nephroma

Search GEO for disease gene expression data for Congenital Mesoblastic Nephroma.

Pathways for Congenital Mesoblastic Nephroma

Pathways related to Congenital Mesoblastic Nephroma according to GeneCards Suite gene sharing:

(show all 21)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.29 YWHAE NTRK3 NTRK2 NTRK1 NRAS KIT
2
Show member pathways
13.1 YWHAE NTRK3 NTRK2 NTRK1 NRAS KIT
3
Show member pathways
12.94 NTRK3 NTRK2 NTRK1 NRAS KIT IGF2
4
Show member pathways
12.81 YWHAE NTRK2 NTRK1 NRAS KIT IGF2
5 12.64 NTRK2 NTRK1 NRAS KIT IGF2
6
Show member pathways
12.6 NTRK2 NTRK1 NRAS KIT IGF2
7
Show member pathways
12.58 YWHAE NTRK3 NTRK2 NTRK1 NRAS
8
Show member pathways
12.54 YWHAE NTRK3 NTRK2 NTRK1 NRAS IGF2
9
Show member pathways
12.38 YWHAE NTRK3 NTRK2 NTRK1 NRAS KIT
10 12.11 WT1 SSX2 NTRK1 ETV6
11
Show member pathways
12.08 YWHAE NTRK3 NTRK2 NTRK1 NRAS
12
Show member pathways
12.06 NTRK3 NTRK2 NTRK1 KIT IGF2
13
Show member pathways
11.99 YWHAE NTRK3 NTRK2 NTRK1 NRAS
14
Show member pathways
11.93 NTRK3 NTRK2 NTRK1 NRAS KIT IGF2
15 11.9 YWHAE NTRK2 NTRK1 KIT
16
Show member pathways
11.5 NTRK3 NTRK2 NTRK1
17 11.46 NTRK3 NTRK2 NTRK1 NRAS IGF2
18 11.31 NTRK3 NTRK2 NTRK1
19 10.89 NTRK3 NTRK2 NTRK1 KIT IGF2
20 10.77 NTRK3 NTRK1 NRAS KIT
21
Show member pathways
10.63 NTRK2 NTRK1

GO Terms for Congenital Mesoblastic Nephroma

Cellular components related to Congenital Mesoblastic Nephroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 receptor complex GO:0043235 9.26 NTRK3 NTRK2 NTRK1 KIT
2 axon GO:0030424 9.02 YWHAE NTRK3 NTRK2 NTRK1 AGBL4

Biological processes related to Congenital Mesoblastic Nephroma according to GeneCards Suite gene sharing:

(show all 18)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.93 WT1 NTRK3 NTRK2 KIT CTCF
2 positive regulation of protein phosphorylation GO:0001934 9.8 NTRK3 NTRK2 NTRK1 IGF2
3 peptidyl-tyrosine phosphorylation GO:0018108 9.76 NTRK3 NTRK2 NTRK1 KIT
4 circadian rhythm GO:0007623 9.73 NTRK3 NTRK2 NTRK1
5 transmembrane receptor protein tyrosine kinase signaling pathway GO:0007169 9.73 NTRK3 NTRK2 NTRK1 KIT
6 positive regulation of synapse assembly GO:0051965 9.69 NTRK3 NTRK2 NTRK1
7 positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068 9.67 NTRK3 NTRK2 NTRK1 KIT
8 cellular response to nerve growth factor stimulus GO:1990090 9.65 NTRK3 NTRK2 NTRK1
9 central nervous system neuron development GO:0021954 9.58 NTRK2 AGBL4
10 regulation of MAPK cascade GO:0043408 9.58 NTRK3 NTRK2 NTRK1
11 regulation of gene expression by genetic imprinting GO:0006349 9.57 IGF2 CTCF
12 positive regulation of kinase activity GO:0033674 9.56 NTRK3 NTRK2 NTRK1 KIT
13 positive regulation of phospholipase C activity GO:0010863 9.55 NTRK3 KIT
14 positive regulation of MAPK cascade GO:0043410 9.55 NTRK3 NTRK2 NTRK1 KIT IGF2
15 neuronal action potential propagation GO:0019227 9.52 NTRK3 NTRK2
16 regulation of protein kinase B signaling GO:0051896 9.5 NTRK3 NTRK2 NTRK1
17 mechanoreceptor differentiation GO:0042490 9.13 NTRK3 NTRK2 NTRK1
18 neurotrophin signaling pathway GO:0038179 8.8 NTRK3 NTRK2 NTRK1

Molecular functions related to Congenital Mesoblastic Nephroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 10.32 YWHAE WT1 VGLL2 SSX2 PLEKHA6 NTRK3
2 protein kinase activity GO:0004672 9.8 NTRK3 NTRK2 NTRK1 KIT CCNB3
3 protein tyrosine kinase activity GO:0004713 9.56 NTRK3 NTRK2 NTRK1 KIT
4 transmembrane receptor protein tyrosine kinase activity GO:0004714 9.46 NTRK3 NTRK2 NTRK1 KIT
5 GPI-linked ephrin receptor activity GO:0005004 9.32 NTRK3 NTRK1
6 neurotrophin binding GO:0043121 9.13 NTRK3 NTRK2 NTRK1
7 neurotrophin receptor activity GO:0005030 8.8 NTRK3 NTRK2 NTRK1

Sources for Congenital Mesoblastic Nephroma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....